Please use this identifier to cite or link to this item: http://hdl.handle.net/11455/38193
標題: Methylation target array for rapid analysis of CpG island hype rmethyl ation in multiple tissue genomes
作者: Chen, C.M.
陳全木
Chen, H.L.
Hsiau, T.H.C.
Hsiau, A.H.A.
Shi, H.D.
Brock, G.J.R.
Wei, S.H.
Caldwell, C.W.
Yan, P.S.
Huang, T.H.M.
關鍵字: tumor-suppressor gene;human breast-cancer;dna methylation;hypermethylation;expression;microarrays
Project: American Journal of Pathology
期刊/報告no:: American Journal of Pathology, Volume 163, Issue 1, Page(s) 37-45.
摘要: 
Hypermethylation of multiple CpG islands is a common event in cancer. To assess the prognostic values of this epigenetic alteration, we developed Methylation Target Array (MTA), derived from the concept of tissue microarray, for simultaneous analysis of DNA hypermethylation in hundreds of tissue genomes. in NITA, linker-ligated CpG island fragments were digested with methylation-sensitive endonucleases and amplified with flanking primers. A panel of 468 NITA amplicons, which represented the whole repertoire of methylated CpG islands in 93 breast tumors, 20 normal breast tissues, and 4 breast cancer cell lines, were arrayed on nylon membrane for probe hybridization. Positive hybridization signals detected in tumor amplicons, but not in normal amplicons, were indicative of aberrant hypermethylation in tumor samples. This is attributed to aberrant sites that were protected from methylation-sensitive restriction and were amplified by PCR in tumor samples, while the same sites were restricted and could not be amplified in normal samples. Hypermethylation frequencies of the 10 genes tested in breast tumors and cancer cell lines were 60% for GPC3, 58% for RASSF1A, 32% for 3OST3B, 30% for HOXA5, 28% for uPA, 25% for WT1, 23% for BRCA1, 9% for DAPK1, and 0% for KL. Furthermore, hypermethylation of 5 to 7 loci of these genes was significantly correlated with hormone receptor status, clinical stages, and ages at diagnosis of the patients analyzed. This novel approach thus provides an additional avenue for assessing clinicopathological consequences of DNA hypermethylation in breast cancer.
URI: http://hdl.handle.net/11455/38193
ISSN: 0002-9440
DOI: 10.1016/s0002-9440(10)63628-0
Appears in Collections:生命科學系所

Show full item record
 

Google ScholarTM

Check

Altmetric

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.